美國居民不適用 XM 服務。
P
P

Pfizer

交易方向

交易者脈動

技術摘要

小時

財經新聞

Nurix Therapeutics drops after upsized $175 mln stock offering

BUZZ-Nurix Therapeutics drops after upsized $175 mln stock offering ** Nurix Therapeutics Inc's NRIX.O shares down 5.3% at $16.30 premarket after overnight follow-on priced ** Biopharma firm late Thurs announced ~11.7 mln shares, including 1.5 mln pre-funded warrants, at $15 for $175 mln gross raise ** Offering size boosted from $125 mln, priced at 12.8% discount to last sale ** Co plans to use net offering proceeds to fund clinical development of drug candidates, fund R&D ** NRIX shares on Tues
G
J
P
S

Pfizer’s Wyeth reaches $39 million settlement in Effexor XR antitrust case

Pfizer’s Wyeth reaches $39 million settlement in Effexor XR antitrust case By Mike Scarcella April 10 (Reuters) - Pfizer PFE.N subsidiary Wyeth has agreed to pay $39 million to resolve claims from drug purchasers that it conspired with rival Teva to delay launching a less-expensive version of the antidepressant drug Effexor XR. Plaintiffs’ lawyers for Rochester Drug Co-Operative, Stephen L.
K
P
T
W

U.S. STOCKS Chemours, Lucid, OppFi

BUZZ-U.S. STOCKS ON THE MOVE-Chemours, Lucid, OppFi Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stocks fell on Tuesday, reversing early gains amid a broad sell-off as investors grew nervous in the run-up to a key inflation print later in the week that could influence the Federal Reserve's policy easing stance this year.
B
G
M
P
R
U
U
P
R
W
H

U.S. STOCKS Digital Realty, Alphabet, Moderna

BUZZ-U.S. STOCKS ON THE MOVE-Digital Realty, Alphabet, Moderna Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes gained on Tuesday supported by retreating Treasury yields, while investors awaited a key inflation print later in the week that could help shape the Federal Reserve's stance on interest-rate cuts this year.
G
M
N
P
R
U
U
R

Pfizer rises as RSV shot succeeds in study of high-risk adults under age 60

BUZZ-Pfizer rises as RSV shot succeeds in study of high-risk adults under age 60 ** Shares of Pfizer PFE.N rise 2.3% to $27.2 ** U.S. drugmaker says its respiratory syncytial virus (RSV) vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the age of 60 similar to that in older adults ** PFE says it plans
P

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明